Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Treating Pulmonary Fibrosis with Stem Cells

Posted by devin@stemsave.com on Jun 3, 2016 3:30:00 PM

Mesenchymal stem cells (MSCs) have been found to aid in the treatment of autoimmune-related lung fibrosis. Interstitial pneumonia is the inflammation of alveoli, and affects patients with pulmonary fibrosis and other connective tissue diseases. Increased fibrosis is due to an overactive immune response--mainly cytotoxic T cells. Past therapies have tried to suppress all immune cells to lower pro-fibrotic molecules. Mesenchymal stem cells are able to selectively change the composition of T cells from cytotoxic to regulatory. Bone marrow derived stem cells interfered with overactive autoimmune processes, and promoted the repair of alveoli tissue.

Read More

Topics: stemsaveblog, autoimmune disease, inflammation, mesenchymal stem cells, connective tissue, pneumonia, lung fibrosis

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all